US4781601046 - JNJ - 853260 (XNYS)
JOHNSON & JOHNSON Share
144,70 USD
Current Prices from JOHNSON & JOHNSON
Exchange | Ticker | Currency | Last Trade | Price | Daily Change | Daily Change % |
---|---|---|---|---|---|---|
NYSE |
JNJ
|
USD
|
21.12.2024 00:27
|
144,70 USD
| 143,58 USD | 0,78 % |
XETRA |
JNJ.DE
|
EUR
|
20.12.2024 17:35
|
138,94 EUR
| 139,12 EUR | -0,13 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | -1,38 % | -6,95 % | -11,86 % | -2,72 % | -7,02 % | -0,93 % |
Company Profile for JOHNSON & JOHNSON Share
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Invested Funds
The following funds have invested in: JOHNSON & JOHNSON invested:
Fund | Vol. in million 11.885,14 | Percentage (%) 7,11 % |
Fund | Vol. in million 21.456,84 | Percentage (%) 5,88 % |
Fund | Vol. in million 1.867,23 | Percentage (%) 3,92 % |
Fund | Vol. in million 12.780,82 | Percentage (%) 3,89 % |
Fund | Vol. in million 8.737,62 | Percentage (%) 3,24 % |
Company Data for JOHNSON & JOHNSON Share
Name JOHNSON & JOHNSON
Company Johnson & Johnson
Symbol JNJ
Website https://www.jnj.com
Primary Exchange
NYSE
WKN 853260
ISIN US4781601046
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Mr. Joaquin Duato
Market Capitalization 366 Mrd.
Country United States of America
Currency USD
Employees 131,9 T
Address One Johnson & Johnson Plaza, 08933 New Brunswick
IPO Date 2007-12-28
Dividenden von 'JOHNSON & JOHNSON'
Ex-Datum | Dividende pro Aktie |
---|---|
26.11.2024 | 1,24 USD |
27.08.2024 | 1,24 USD |
20.05.2024 | 1,24 USD |
16.02.2024 | 1,19 USD |
20.11.2023 | 1,19 USD |
25.08.2023 | 1,19 USD |
22.05.2023 | 1,19 USD |
17.02.2023 | 1,13 USD |
21.11.2022 | 1,13 USD |
22.08.2022 | 1,13 USD |
Aktien-Splits
Datum | Split |
---|---|
13.06.2001 | 2:1 |
12.06.1996 | 2:1 |
10.06.1992 | 2:1 |
11.05.1989 | 2:1 |
19.05.1981 | 3:1 |
18.05.1970 | 3:1 |
19.06.1967 | 3:1 |
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | JNJ.F |
NYSE | JNJ |
XETRA | JNJ.DE |
Weitere Aktien
Investoren die JOHNSON & JOHNSON die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.